06th week of 2009 patent applcation highlights part 38 |
Patent application number | Title | Published |
20090035165 | Addressable Multi-Channel Peristaltic Pump - The present invention provides an addressable multi-channel peristaltic pump. According to the invention, this pump design allows for selection and operation of one or more pump heads on a drive shaft, while locking other non-selected pump heads in a stationary position. It is possible to operate the multi-channel pump using a limited number of motors, preferably two motors: a selector motor and a dispense motor. Thus, the pump provides for pumping or dispensing of one or more fluids without the need for multiple pumps. Likewise, compared with typical single motor multi-channel systems, where all pump heads on the drive shaft must rotate at the same time, the present invention provides for selective dispensing of one or more fluids. The pumps of the present invention are suitable for any multiple fluid transfer application, including in automated multi-channel reagent dispensing systems, such as nucleic acid purification systems. | 2009-02-05 |
20090035166 | TWO-STAGE ROTARY COMPRESSOR - A two-stage rotary compressor having a compression mechanism including a single muffler housing member. The single muffler housing member at least partially defines an intermediate pressure discharge cavity and a discharge pressure discharge cavity. In one exemplary embodiment, the compression mechanism includes a cylinder block having a plurality of vanes positioned within slots formed in an inner cylindrical surface of the cylinder block. The slots are in fluid communication with the discharge pressure discharge cavity and receive discharge pressure working fluid to bias the vanes radially inwardly. In another exemplary embodiment, the cylinder block includes a plurality of passages for the delivery of working fluid to and from the cylinder block. | 2009-02-05 |
20090035167 | STEPPED SCROLL COMPRESSOR WITH STAGED CAPACITY MODULATION - A scroll compressor has a stepped wrap such that there is a greater height outer portion and a lesser height more central portion. Bypass ports are associated with the transition zone between the higher and lesser height portions. By providing the bypass port in a stepped scroll compressor, greater reductions in capacity can be achieved than have been provided in the prior art. | 2009-02-05 |
20090035168 | Scroll-type refrigerant compressor - The invention relates to a scroll-type refrigerant compressor The inventive compressor comprises: a sealed chamber which is defined by a ferrule ( | 2009-02-05 |
20090035169 | Dual metal torque transmitting apparatuses and methods for making the same - Apparatuses and methods are provided for transmitting torque in a way that can prolong the life of such apparatuses by using dissimilar materials for a body region and a torque transmitting region that absorbs the wear of the apparatuses, the apparatuses being constructed by methods of powder metallurgy. A torque transmitting apparatus can be provided and can include an annular body member composed of a first material and an outer ring member composed of a second powder metal material. The outer ring member can shrink about the annular body member during a sintering phase to form a single body in which the outer ring member can be fixedly attached to the annular body member. | 2009-02-05 |
20090035170 | R-T-B TYPE ALLOY AND PRODUCTION METHOD THEREOF, FINE POWDER FOR R-T-B TYPE RARE EARTH PERMANENT MAGNET, AND R-T-B TYPE RARE EARTH PERMANENT MAGNET - An object of the present invention is to provide an R-T-B type alloy (wherein R is at least one element selected from Sc, Y, La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Ho, Er, Tm, Yb, and Lu; T is a transition metal that contains 80% by mass or more of Fe; and B is one that contains 50% by mass or more of boron (B) and also contains at least one element of C and N within a range from 0 to less than 50% by mass) that contains at least Dy, as a raw material for a rare earth-based permanent magnet having excellent magnetic characteristics, and the R-T-B type alloy provided in the present invention includes a main phase such as an R | 2009-02-05 |
20090035171 | High-Strength And High-Toughness Magnesium Alloy And Method For Manufacturing Same - Provided is a high-strength and high-toughness magnesium alloy which has practical level of both the strength and the toughness for expanded applications of the magnesium alloys, and is a method for manufacturing thereof. The high-strength and high-toughness magnesium alloy of the present invention contains: a atom % in total of at least one metal of Cu, Ni, and Co; and b atom % in total of at least one element selected from the group consisting of Y, Dy, Er, Ho, Gd, Tb, and Tm, while a and b satisfying the following formulae (1) to (3), | 2009-02-05 |
20090035172 | Titanium Alloy - The invention relates to a titanium alloy which, even under the influence of high application temperatures, has a low tendency to becoming brittle as a result of coarse grain formation. The titanium alloy thus comprises (in wt. %) Fe:=2%, Si:0.1=0.8%, O:=0.3%, C:=0.1%, one or more elements of the Lanthanide group at total levels of 0.01-2% and, optionally, one or more elements from the group Al, O at total levels of a maximum of 1%, one or more elements from the group Mo, Ta, Nb, Zr, Mn, Cr, Co, Ni, Cu, V, Si, or H at total levels of a maximum of 3%, the remainder being titanium and unavoidable impurities. | 2009-02-05 |
20090035173 | Electrically Conductive Material - An electrically conductive material includes: a supersaturated solid solution of a polycrystalline copper alloy having a composition represented by the formula: Cu | 2009-02-05 |
20090035174 | Copper Alloy for Electronic Materials - The invention provides Cu—Ni—Si alloys containing Co, and having excellent strength and conductivity. A copper alloy for electronic materials in accordance with the invention contains about 0.5-about 2.5% by weight of Ni, about 0.5-about 2.5% by weight of Co, about 0.30-about 1.2% by weight of Si, and the balance being Cu and unavoidable impurities, wherein the ratio of the total weight of Ni and Co to the weight of Si ([Ni+Co]/Si ratio) satisfies the formula: about 4≦[Ni+Co]/Si≦about 5, and the ratio of Ni to Co (Ni/Co ratio) satisfies the formula: about 0.5≦Ni/Co≦about 2. | 2009-02-05 |
20090035175 | HYDROGEN STORAGE MATERIAL - An unactivated, poorly activatable hydrogen storage component and an activated hydrogen storage component are mixed to prepare a hydrogen storage material. When the hydrogen storage material is activated, the poorly activatable hydrogen storage component is converted to a hydrogen storable state in a remarkably short time. The poorly activatable hydrogen storage component may be a V—Cr—Ti hydrogen storage alloy having a body-centered cubic (BCC) crystal structure. The activated hydrogen storage component preferably is MgH | 2009-02-05 |
20090035176 | Method and Device for Purifying Ambient Air and Surfaces - Described is an air and surface purifying device having a purifying cell structured for maximizing the realized photocatalytic reaction at a photocatalytic surface without using an additional ultraviolet bulb. The purifying cell positions at least three photocatalytic surfaces about a single ultraviolet bulb such that the photocatalytic surfaces substantially encompass the ultraviolet bulb and are saturated by ultraviolet light radiating from the ultraviolet bulb. Because the photocatalytic surfaces are saturated, the potential photocatalytic reaction at the photocatalytic surfaces is fully realized. Stated differently, the realized photocatalytic reaction is maximized. Because the purifying cell maximizes the realized photocatalytic reaction, the purifying cell maximizes the purifying capacity of the photocatalytic surface and, thus, the purifying cell itself. | 2009-02-05 |
20090035177 | Paddle fan medallion and methods for enhancement of room air quality - Accessories and methods for ceiling paddle fan fixtures for enhancing room air quality and killing common air borne viruses by air sterilization immediately within the room where the germs originate in a relatively large and diffuse sterilization zone at a relatively low UV radiation level through which a relatively high volume of air is circulated by a paddle fan. | 2009-02-05 |
20090035178 | PROCESS FOR THE DESTRUCTION OF MICROORGANISMS ON A PRODUCT - A process for the destruction of microorganisms on a product using ultrasonic energy is disclosed. The process comprises contacting a product with an ultrasonic horn assembly and generating ultrasonic energy sufficient to result in a microorganism destruction rate of at least a 1-log kill. | 2009-02-05 |
20090035179 | COLORIMETRIC SENSOR - Colorimetric sensor films comprising a reflective layer, a polymeric detection layer, and a semi-reflective layer are disclosed. Devices comprising the calorimetric sensor films and methods of making the films and devices are also disclosed. | 2009-02-05 |
20090035180 | CONTROL SYSTEM FOR INDUSTRIAL WATER SYSTEM AND METHOD FOR ITS USE - A control system for industrial water systems that utilizes multiple measurements of information and models to decide optimal control actions to maximize corrosion/scaling/fouling inhibition and particulate dispersancy performance and minimize cost of water and treatment chemicals. This system is capable of automatic operation for a wide range of process conditions, ensures multiple performance objectives, achieves robust operation under a variety or un-measurable disturbances and achieves the least costly solution delivery. | 2009-02-05 |
20090035181 | MOBILE ROBOT AND CLINICAL TEST APPARATUS USING THE SAME - A clinical test apparatus employing a mobile robot is provided. The clinical test apparatus includes a stage unit, a test station provided in the stage unit and configured to perform a clinical test, a mobile robot configured to move on a top surface of the stage unit and to transfer a plate on which samples and reagents are loaded to the test station, and a docking unit disposed in the stage unit and configured to reset a position of the mobile robot. A variety of test stations for a clinical test can be integrated, and multiple tests can be performed at the same time through a plurality of mobile robots. | 2009-02-05 |
20090035182 | AUTOMATIC ANALYZER - An object of the present invention is to provide an automatic analyzer which measures blank values for each vessel to reduce analysis time. | 2009-02-05 |
20090035183 | Method and apparatus for real-time analysis of chemical, biological and explosive substances in the air - A device for real-time analysis of airborne chemical, biological and explosive substances has at least a gas analysis sensor, a fluorescence/luminescence sensor and a sensor for determining the particle size and number of particles. Each of the sensors is connected to a multireflection cell (multipass laser cell) as an open measurement path. In addition, the device also includes an evaluation unit for the real-time analysis of chemical, biological and explosive substances. | 2009-02-05 |
20090035184 | HYDROGEN GAS SENSOR - The present invention provides a catalytic combustion type hydrogen gas sensor of a simple structure, which is capable of inhibiting the degradation of the sensitivity thereof over a long period of time even in the presence of a silicon compound being a catalyst poison. This hydrogen gas sensor is equipped with a detection element | 2009-02-05 |
20090035185 | SPECIMEN PREPROCESSING SYSTEM - A specimen preprocessing system including a specimen rack which supports a specimen container with its opening sealed with a plug for storing the specimen, a carrier line for carrying the specimen rack, a preprocessing unit to which the specimen rack is carried by the carrier line, and a control unit for controlling the carrier line and the preprocessing unit is provided with a plug opening unit which is capable of opening plugs of the specimen containers each having a different height (different plug configuration or diameter) mounted in the same specimen rack. | 2009-02-05 |
20090035186 | APPARATUS AND METHOD FOR DISPENSING LIQUID UTILIZING FLOW OF FLUID - An apparatus for accurately and precisely aspirating and dispensing liquid from a in the nano-liter range without contacting the syringe tip to the target reservoir during dispensing; and a method to utilize such an apparatus. Such an apparatus utilizes a partially collapsible syringe tip that compresses when subjected to pressurized fluid around its outer surface area to discharge a liquid at the tip of said partially collapsible syringe tip with a high velocity. Such a discharge of liquid at such a high speed allows even the smallest amount of liquid in the nano-liter range to be dispensed to a target reservoir without contacting the target reservoir. | 2009-02-05 |
20090035187 | Microarray assay devices and methods of making and using the same - Aspects of the invention include systems for producing microarray assay devices. Further aspects of the invention include assembled microarray assay devices, as well as methods of assembling the devices and methods of using the assembled devices. | 2009-02-05 |
20090035188 | FRAGRANCE EMITTING APPARATUS - A fragrance emitting apparatus includes a case, a heat conducting board mounted in the case, a fragrance container disposed in the case and contacting the heat conducting board, a heater disposed in the case and contacting the heat conducting board, and a temperature control apparatus connected to the heater and configured to control the heater to heat the heat conducting board according to the temperature thereof. | 2009-02-05 |
20090035189 | STERILIZATION/DISINFECTION CYCLE CONTROL - A sterilizer includes a vacuum chamber, a source of vaporizable sterilant, a vacuum pump, and a control system. The control system is programmed to take one or more data inputs regarding the nature of the load, such as lumen length and diameter, and determine one or more parameters of the sterilization cycle based upon the inputs. | 2009-02-05 |
20090035190 | Sports Figure Air Freshener With Movable Ball - The present invention provides for an air freshener in the shape of a sports figure that has a sports ball-shaped piece attached via a flexible strip that moves freely towards and away from the sports figure as the air-freshener moves. The air-freshener comprises a sports figure-shaped air freshener, a ball-shaped piece, a hanger for hanging the air freshener from a rearview mirror and a flexible strip that attaches the ball-shaped piece to the hanger. In one preferred embodiment, the air freshener depicts a football player, and the ball-shaped piece is shaped like a football. In another preferred embodiment, the air freshener depicts a soccer player, and the ball-shaped piece is shaped like a soccer ball. As the air freshener moves, the flexible strip moves and the ball moves towards and away from the sports figure. The flexible strip is of an appropriate length so that the ball-shaped piece contacts the foot of the soccer player or the hands of the football player when the flexible strip has moved the ball-shaped piece adjacent to the body of the sports figure. | 2009-02-05 |
20090035191 | Apparatus for Heating Regeneration Gas - Disclosed is an apparatus for combusting dry gas to heat the air fed to an FCC regenerator to increase its temperature and minimize production of undesirable combustion products. Preferably, the dry gas is a selected FCC product gas. Alternatively or additionally, dry gas from an FCC product stream is separated and delivered to an expander to recover power before combustion. | 2009-02-05 |
20090035192 | Catalytic EGR oxidizer for IC engines and gas turbines - By using catalytic partial oxidation or autothermal reforming process, a catalytic oxidizer installed in the engine's Exhaust Gas Recycle (EGR) line can be used to produce from fossil fuels or bio-fuels a reformate gas containing H | 2009-02-05 |
20090035193 | Apparatus for Recovering Power from FCC Product - Disclosed is an apparatus for recovering power from an FCC product. The dry gas is combusted and combined with FCC regenerator flue gas to raise the power recovery capability of the flue gas. The flue gas can be used to generate electrical power or steam. Alternatively or additionally, dry gas from an FCC product stream is separated and delivered to an expander to recover power before combustion. | 2009-02-05 |
20090035194 | Exhaust treatment system with an oxidation device for NO2 control - An exhaust treatment system includes an oxidation device having a plurality of channels through which a flow of exhaust flows. A first portion of the channels of the oxidation device are coated with catalytic material for converting NO to NO | 2009-02-05 |
20090035195 | Exhaust treatment system with NO2 control - An exhaust treatment system includes a catalyzed particulate filter disposed in a first passageway and configured to receive a first portion of a flow of exhaust. The catalyzed particulate filter is at least partially coated with a catalytic material for converting NO to NO | 2009-02-05 |
20090035196 | DEVICE FOR GASEOUS PLASMA STERILIZATION - A device for producing a gas plasma by ionisation of a gas using a microwave source of determined nominal power (P | 2009-02-05 |
20090035197 | Alkylation Process with Recontacting in Settler - A system and/or process for decreasing the level of at least one organic fluoride present in a hydrocarbon phase contained in an alkylation settler by contacting the hydrocarbon phase with an HF containing stream, containing greater than about 80 wt. % and less than about 94 wt. % HF, in the intermediate portion of the settler which contains at least one tray system, with each tray system comprising a perforated tray defining a plurality of perforations and a layer of packing below the perforated tray, are disclosed. | 2009-02-05 |
20090035198 | HYDROCARBON CONVERSION UNIT INCLUDING A REACTION ZONE RECEIVING TRANSFERRED CATALYST - One exemplary embodiment can include an apparatus for transferring catalyst from a regeneration zone to a reaction zone in a hydrocarbon conversion unit. The hydrocarbon conversion unit can include a transfer vessel, and first, second, and third lines. The transfer vessel can transfer regenerated catalyst from the regeneration zone at a first pressure to the reaction zone at a second pressure where the second pressure is greater than the first pressure. Generally, the first line communicates the catalyst to the transfer vessel and is coupled to a first valve to allow catalyst into the transfer vessel and the second line communicates the catalyst from the transfer vessel and is coupled to a second valve to allow catalyst out of the transfer vessel. The third line for allowing the passage of gas therethrough may be at a pressure higher than the first pressure having a first portion communicating with the transfer vessel and having a second portion coupled to third and fourth valves. Each of the third and fourth valves can have a first position that is open and a second position that is closed, which may correspond, respectively, to the opening and closing of the first and second valves to allow gas to pass therethrough. | 2009-02-05 |
20090035199 | METHOD FOR SOUR GAS TREATMENT - A method for selectively removing hydrogen sulfide and carbon dioxide from sour gas by reacting the hydrogen sulfide and carbon dioxide in the sour gas with sodium hydroxide is disclosed. Also disclosed is a process for the production of a salt product from a sour gas stream. The reaction with sodium hydroxide creates a scrubber solution comprising water, hydrocarbons, contaminants and salts. The scrubber solution may be oxidized, filtered and can then be subjected to electrodialysis. Ammonia is introduced into the acid compartments of the cell. Sodium hydroxide and a salt product comprising ammonium sulfate or ammonium thiosulfate with ammonium bicarbonate, ammonium carbonate, ammonium carbamate may be produced. The regenerated sodium hydroxide may be used to sweeten further sour gas. The salt product may be used as a fertilizer. | 2009-02-05 |
20090035200 | LOW-TEMPERATURE, MOVING BED CATALYTIC REACTOR FOR CONTROL OF NOx EMISSIONS FROM COMBUSTION - An apparatus for low-temperature NO | 2009-02-05 |
20090035201 | PREPARATION METHOD OF TC-99M-LABELED IRON OXIDE NANOPARTICLE AND DIAGNOSTIC IMAGING OR THERAPEUTIC AGENT FOR CANCER DISEASES COMPRISING THE SAME - Disclosed herein are a method of preparing a technetium-99m-labeled iron oxide (Fe | 2009-02-05 |
20090035202 | Cerium Oxide-Based Abrasive, and Production Method and Use Thereof - The present invention provides a cerium oxide-based abrasive ensuring high removal rate, less generation of scratches, high-precision polished surface with small surface roughness, and a safe, simple and low-cost production process. Further, the present invention provides a method for producing such an abrasive. The method of the present invention comprises (a) adding a precipitant to an aqueous cerium-containing light rare-earth salt solution to precipitate a light rare-earth salt, thereby obtaining a first slurry containing a light rare-earth salt particle; (b) adding a fluorinating agent to a slurry containing a light rare-earth salt particle to react the light rare-earth salt with the fluorinating agent, thereby obtaining a second slurry containing a light rare-earth fluoride particle; (c) mixing the first slurry and the second slurry to obtain a mixed slurry; and (d) drying and firing the mixed slurry, and a cerium oxide-based abrasive obtained by this method. The abrasive of the present invention is produced by the method of the present invention. | 2009-02-05 |
20090035203 | PRODUCTION METHOD OF BLUE LIGHT-EMITTING PHOSPHOR - A method ensuring that a CaMgSi | 2009-02-05 |
20090035204 | Methods for Synthesizing Lithium Iron Phosphate as a Material for the Cathode of Lithium Batteries - A method for synthesizing lithium iron phosphate as a material for the cathode of lithium batteries is disclosed. This method comprises mixing and sintering the lithium source, iron source, phosphorous source, and carbon source, wherein said iron source is a mixture of FeC | 2009-02-05 |
20090035205 | PROCESS FOR PREPARING HSiCI3 BY CATALYTIC HYDRODEHALOGENATION OF SiCl4 - The invention relates to a process for the catalytic hydrodehalogenation of SiCl | 2009-02-05 |
20090035206 | Ammonia Synthesis Process - In an industrial scale ammonia synthesis process ( | 2009-02-05 |
20090035207 | METHOD AND DEVICE FOR SEPARATING A GAS MIXTURE - A method and device for producing a carbon dioxide product from a feed gas comprised predominantly of carbon dioxide and nitrogen in a cryogenic gas separation process is disclosed. The nitrogen is separated from carbon dioxide in a one-stage condensation process in two separators that are connected in series. | 2009-02-05 |
20090035208 | Nanoporous Catalyst Particles, the Production Thereof and Their Use - The invention relates to nanoporous catalyst particles having a spherical and/or spheroidal secondary structure, which contain, as catalytically active constituents, transition metals and/or oxides or precursors thereof. The invention also relates to a method for producing the nanoporous catalyst particles, during which, by means of a precipitation process, precursors with a spherical and/or spheroidal preliminary shape are produced from soluble compounds of the active constituents, and these morphologically pre-shaped precursors are, in a thermal activation step, transformed into nanoporous catalyst particles having a spherical and/or spheroidal secondary structure. The inventive catalyst particles can be used in the production of ceramic materials, as electrode materials in electrochemical cells or in fuel cells, as storage materials for chemical species and, in particular, in the production of carbon nanoparticles in the form of small tubes or fibers. | 2009-02-05 |
20090035209 | METHOD OF MANUFACTURING CARBON NANOTUBE - According to a method of manufacturing carbon nanotubes, minute concavities and convexities are formed at a surface of a substrate, a catalyst metal layer having a predetermined film thickness is formed on the surface having the concavities and convexities, the substrate is subject to a heat treatment at a predetermined temperature to change the catalyst metal layer into a plurality of isolated fine particles. The catalyst metal fine particles have a uniform particle diameter and uniform distribution. Then, the substrate supporting the plurality of fine particles is placed in a carbon-containing gas atmosphere to grow carbon nanotubes on the catalyst metal fine particles by a CVD method using the carbon-containing gas. The carbon nanotubes can be formed to have a desired diameter and a desired shell number with superior reproducibility. | 2009-02-05 |
20090035210 | CARBON BLACK - Carbon black with an OAN, measured on the beaded carbon black, of less than 120 ml/100 g. A process for the preparation of the carbon black is described, wherein a salt solution is converted into an aerosol and this is then introduced into the carbon black formation zone. The carbon black can be used in inks, paints, lacquers, printing inks and ink-jet inks, and for coloring plastics. | 2009-02-05 |
20090035211 | DEVICE FOR ENERGETICALLY UTILIZING SOLID WASTE - The invention relates to a device for energetically utilizing solid waste. The term “solid waste” refers, for example, to waste paper, scrap wood, plastic waste, production waste, industrial sludge or other solid fractions containing combustible constituents, or mixtures thereof. The aim of the invention is to create a device for thermally utilizing solid waste, which has a neutral if not even positive energy balance and is suitable for a wide range of waste materials while paying special attention to environmental relevance, especially the flue-gas composition. The aim is achieved by providing the inventive device with a material-feed mechanism, a charring apparatus and a thermal post-combustion apparatus. These basic components make it possible to utilize many different types of solid waste, the feedstock initially being transformed into hot gas which can be converted into steam and power as required. | 2009-02-05 |
20090035212 | Method for Concentrating Oxygen Isotope or Isotopes - The method for concentrating an oxygen isotope or isotopes of the present invention combines the step of concentrating | 2009-02-05 |
20090035213 | Process for producing crystalline titanium oxide coating film through electrolytic anodizing - This invention aims to provide a method for producing a crystalline titanium oxide film that is suitable for industrial production; that forms a large amount of crystalline titanium oxide; and that is useful as a photocatalyst, a photovoltaic element, and the like. Such a crystalline titanium oxide film is produced through the following steps (a-1) and (b): (a-1) a step of heating titanium or titanium alloy under either of the following conditions (1) to (3) to form titanium nitride on the surface of the titanium or titanium alloy; (1) in an atmosphere of nitrogen and/or ammonia gas in the presence of an oxygen trapping agent; (2) in an atmosphere where a pressure is reduced to discharge atmospheric gas, and then nitrogen and/or ammonia gas are/is introduced; or (3) in an atmosphere where a pressure is reduced to discharge atmospheric gas, and then nitrogen and/or ammonia gas are/is introduced in the presence of oxygen trapping agent; and (b) a step of immersing the titanium or titanium alloy obtained in step (a-1) above in an electrolyte containing an inorganic acid and/or organic acid, and applying voltage for anodization. | 2009-02-05 |
20090035214 | CONTROL SYSTEM FOR AN ON-DEMAND GAS GENERATOR - A self-regulating on-demand gas generator. Generation of gas produced from a reaction is selectively, variably, and spontaneously controlled. A variable volume liquid chamber in communication with the pressure pot allows the volume of liquid reactant in the pressure pot to be varied. The amount of product gas generated in the pressure pot depends on the degree of contact between the solid-like reactant and the liquid reactant. The pressure of the product gas regulates the level of liquid in the pressure pot and thereby regulates the degree of contact between the solid-like reactant and the liquid reactant. A sealed gas chamber sharing a flexible diaphragm with the liquid chamber controls the expandability of the liquid chamber. Manipulating the pressure in the sealed gas chamber or the volume of the liquid reactant affects the pressure at which contact by the reactants will be initiated or terminated and thereby provides the ability to control the reaction. | 2009-02-05 |
20090035215 | RADIOFLUORINATION - The present invention relates to novel compounds suitable for or already radiolabeled with | 2009-02-05 |
20090035216 | Method for determining in vivo biopharmaceutical concentration or bioavailability - The invention provides a method for determining the bioavailability of single light chain bio-agents in biological samples. The method determines that bioavailability by utilising a labelled form of the bio-agent and incubating with a probe that binds for the alternative light chain antibody form as compared to the form of the bio-agent, followed by a fractionation step where the probe, with any bound bio-agent, is isolated and the level of label from the labelled bio-agent is determined. | 2009-02-05 |
20090035217 | Truncated Fragments of Alpha-Synuclein in Lewy Body Disease - The application identifies novel fragments of alpha-synuclein in patients with Lewy Body Disease (LBD) and transgenic animal models thereof. These diseases are characterized by aggregations of alpha-synuclein. The fragments have a truncated C-terminus relative to full-length alpha-synuclein. Some fragments are characterized by a molecular weight of about 12 kDa as determined by SDS gel electrophoresis in tricine buffer and a truncation of at least ten contiguous amino acids from the C-terminus of natural alpha-synuclein. The site of cleavage preferably occurs after residue 117 and before residue 126 of natural alpha-synuclein. The identification of these novel fragments of alpha-synuclein has a number of application in for example, drug discovery, diagnostics, therapeutics, and transgenic animals. | 2009-02-05 |
20090035218 | SYSTEMS AND METHODS FOR TISSUE IMAGING - The present invention provides systems and methods for monitoring tissue regions. In particular, the present invention provides systems and methods for detecting changes in tissue regions over a period of time. In some embodiments, the systems and methods of the present invention are used to evaluate the effectiveness of a particular treatment of a tissue region. In some embodiments, the systems and methods employ functional diffusion map algorithms for imaging changes in tissue regions over time and/or in response to therapeutic interventions. | 2009-02-05 |
20090035219 | CB1 receptor antagonists and uses thereof - Neutral antagonists of the CB1 cannabinoid receptor, means for identifying neutral antagonists of the CB1 cannabinoid receptor, and uses thereof. Antagonists of the CB1 cannabinoid receptor can be used to prevent, treat or reduce the severity of various medical conditions and symptoms, including, but not limited to obesity, appetite disorder, another metabolic disorder, drug addiction and/or mental illness. Administering neutral CB1 cannabinoid receptor antagonists in place of or in combination with known CB1 cannabinoid receptor antagonists or inverse CB1 cannabinoid receptor agonists in an individual or animal to treat a medical condition with a reduction of unwanted side effects. A method of detecting a neutral CB1 cannabinoid receptor antagonist, including identifying a candidate compound; subjecting the candidate compound to one or more of a cAMP assay, CB1 competitive binding assay, food intake assay, thermoregulation assay, or emesis assay; and selecting the compound if it exhibits neutral antagonist activity. | 2009-02-05 |
20090035220 | HIGH THROUGHPUT SCREENING SYSTEM AND METHOD - A high throughput screening method for determining the pharmacological effect of a given agent, the method comprising, providing an assay plate with at least one sample well, where at least one well contains a volume of media and at least one zebrafish, introducing at least one agent to at least one of the wells with the media and zebrafish and incubating for a given amount of time, providing an electrical stimulus to the plate so as to promote a locomotor response in the zebrafish, and detecting the locomotor response of the zebrafish in response to the electrical stimulus in each well an agent was added to relative to a control well. Also disclosed is an assay plate that includes a first electrode located substantially at the center of the bottom portion of the well and a second electrode located substantially around the circumference of the well wall. | 2009-02-05 |
20090035222 | Techniques for Identifying Molecular Structures and Treating Cell Types Lining a Body Lumen Using Fluorescence - Techniques for detecting fluorescence emitted by molecular constituents in a wall of a body lumen include introducing an autonomous solid support into the body lumen. Cells in a lumen wall of the body lumen are illuminated by a light source mounted to the solid support with a wavelength that excites a particular fluorescent signal. A detector mounted to the solid support detects whether illuminated cells emit the particular fluorescent signal. If the particular fluorescent signal is detected from the illuminated cells, then intensity or position in the lumen wall of the detected fluorescent signal, or both, is determined. These techniques allow the information collected by the capsule to support diagnosis and therapy of GI cancer and other intestinal pathologies and syndromes. For example, these techniques allow diagnostic imaging using endogenous and exogenous fluoroprobes, treating diseased sites by targeted release of drug with or without photoactivation, and determining therapeutic efficacy. | 2009-02-05 |
20090035223 | BIOMIMETIC IRON-OXIDE-CONTAINING LIPOPROTEIN AND RELATED MATERIALS - An engineered lipoprotein including (a) a core particle or a plurality of core particles, each core particle has (i) an inner part comprising a hydrophilic active agent and a hydrophilic portion of an amphiphilic cholesterol and (ii) an outer part including a hydrophobic portion of the amphiphilic cholesterol, (b) a layer surrounding the core particle or a plurality of core particles, the layer includes a phospholipid, (c) an apoprotein associated with the layer, and optionally, (d) a homing molecule associated with at least one of the apoprotein or the phospholipid. | 2009-02-05 |
20090035224 | Methods of Using Albuterol and Calcium Activated Potassium Channel Openers - This invention related to methods of treating, preventing and managing various pulmonary or respiratory diseases or disorders using albuterol in combination with calcium activated potassium channel openers. Pharmaceuticals compositions comprising albuterol and calcium activated potassium channel openers are also disclosed. | 2009-02-05 |
20090035225 | RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA - RNA interference is provided for inhibition of tumor necrosis factor α (TNFα) by silencing TNFα cell surface receptor TNF receptor-1 (TNFR1) mRNA expression, or by silencing TNFα converting enzyme (TACE/ADAM17) mRNA expression. Silencing such TNFα targets, in particular, is useful for treating patients having a TNFα-related condition or at risk of developing a TNFα-related condition such as the ocular conditions associated with elevated intraocular pressure (IOP), including glaucoma and ocular hypertension. | 2009-02-05 |
20090035226 | USE OF CRANBERRY EXTRACT ENRICHED IN TOTAL PHENOLS AND FREE, ESSENTIALLY FREE, OR SUBSTANTIALLY FREE OF SUGARS, ACIDS, SULFUR AND OTHER CONTAMINANTS, FOR PERIODONTAL TREATMENT - Cranberry and other plant extracts enriched in total phenols and free or substantially free of sugars, acids, sulfur and other contaminants are used for periodontal treatments. The periodontal treatments of the present invention include swish and swallow techniques, in which the extracts enriched in total phenols but free or substantially free of sugars, acids, sulfur and other contaminants, are solubilized in water or other solvent, placed in the mouth, swished around the teeth and then swallowed. Other application techniques include gel applications, gum formulations and toothpaste formulations. | 2009-02-05 |
20090035227 | CONFECTIONERY PRODUCTS COMPRISING A TOOTH-FRIENDLY SWEETENER - Confectionery products comprising a tooth-friendly sweetener, bioactive glass particles and at least one product additive, as well as processes for obtaining the products and various applications thereof. | 2009-02-05 |
20090035228 | SKIN AND SURFACE DISINFECTANT COMPOSITIONS CONTAINING BOTANICALS - The present invention relates to a skin or surface disinfectant composition with broad spectrum antimicrobial activity comprising one or more essential oil (and/or one or more component thereof) and one or more fruit acid. The compositions of the invention may be used as non-toxic alternatives to conventional disinfectants or may be added to other antimicrobial agents to enhance their activity. The invention provides effective alternatives to harsher products which may be particularly useful in personal care and household products and where children and/or pet exposure may be a concern. | 2009-02-05 |
20090035229 | PHARMACEUTICAL COMPOSITION FOR IMPROVING ORAL HYGIENE AND METHODS THEREOF - An aqueous based pharmaceutical composition for use as a oral hygienic treatment is described. The composition contains a pharmaceutically effective amount of a tetracycline-based antibiotic; a water-soluble calcium salt that aids in solubilizing the tetracycline-based antibiotic; a thickener; a pH adjustment agent; an antifoaming agent; an excipient; a surfactant; a preservative; and a flavoring agent. A method of making the aqueous based pharmaceutical composition includes the steps of adjusting, defoaming, dispensing, dispersing, dissolving, flavoring, heating, minimizing, pouring, solubilizing, suspending, and sweetening. A method of using the aqueous based pharmaceutical composition is also disclosed which includes the steps of expectorating, gargling, obtaining, pouring, receiving, and swishing. | 2009-02-05 |
20090035230 | Permanganate containing whitening compositions and methods of their use - In general, the invention provides a fast-acting, whitening composition containing permanganate. Particular alkali-metal or alkaline-earth metal salts of permanganate; hydrogen peroxide; or an alkali or alkaline-earth metal peroxide; and an acid. | 2009-02-05 |
20090035231 | TOPICAL ORAL COMPOSITION - A topical oral composition in an orally acceptable carrier, the composition comprising: dehydroacetic acid, a peroxide source and optionally sodium lauryl sulfoacetate, gelling agents, flavors, and abrasives. | 2009-02-05 |
20090035232 | FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC - The invention relates to a fixed-dose association of 5 phytate and zinc in synergic proportions for use in the treatment of crystallisation of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said 10 association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallisation of hydroxyapatite in humans. | 2009-02-05 |
20090035233 | Conversion of liquid formulations to a powder - A powdered composition comprising a liquid or semisolid formulation and a polymeric microparticle delivery system. The powdered composition is capable of converting to the liquid or semisolid composition upon application to a substrate, such as skin or a scalp. | 2009-02-05 |
20090035234 | CONTINUOUS SPRAY SUNSCREEN COMPOSITIONS - The present disclosure generally relates to sunscreen compositions that are suitable for topical application to human skin and hair. More particularly, the disclosure relates to sprayable sunscreen compositions having improved water resistance and a low overall percentage of sunscreen actives. To achieve the improved water resistance, a dimethicone derivative is incorporated into the sunscreen compositions. | 2009-02-05 |
20090035235 | Cosmetic composition for combating the cutaneous consequences of pollution - The invention relates to the use of the extracts of plants of the genus | 2009-02-05 |
20090035236 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent - An emulsion cosmetic composition comprising at least one resveratrol derivative, an aqueous phase, and an oil phase having at and at least one oil phase structuring agent, and a method for preparing emulsions capable of delivering active resveratrol to the skin. | 2009-02-05 |
20090035237 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant - An emulsion cosmetic composition comprising at least one resveratrol derivative, an aqueous phase, and an oil phase, having at least one silicone surfactant, and a method for preparing emulsions capable of delivering active resveratrol to the skin. | 2009-02-05 |
20090035238 | UV FILTER CAPSULE CONTAINING AN AMINO-SUBSTITUTED HYDROXYBENZOPHENONE - The present invention relates to UV filter capsules comprising at least one aminosubstituted hydroxybenzophenone, to the use thereof for producing cosmetic or dermatological formulations and preformulations, and to cosmetic or dermatological formulations which comprise the capsules, and to methods for the production thereof. | 2009-02-05 |
20090035239 | Eye-shadow and process for its preparation - New eye-shadow and process for the preparation thereof, characterised in that the conventional stage of preparation of the powder cake is followed by two further stages: an intermediate stage at which the cake is wetted with an oily compound, and a final stage at which the oily compound is absorbed. | 2009-02-05 |
20090035240 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent - An aqueous based cosmetic composition comprising at least one resveratrol derivative and a water phase containing at least one aqueous phase structuring agent; or an emulsion composition comprising at least one water phase, at least one oil phase containing at least one nonvolatile silicone, and at least one resveratrol derivative. | 2009-02-05 |
20090035241 | Colouring composition for the skin comprising a self-tanning agent and a dye obtained by reacting an amine with dehydroascorbic acid or a monomeric polymeric or isomeric derivative thereof - The present invention relates to a composition for artificially colouring the skin, comprising, in a physiologically acceptable medium:
| 2009-02-05 |
20090035242 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone - An emulsion cosmetic composition comprising at least one resveratrol derivative, a water phase, and an oil phase containing at least one linear or branched volatile or near volatile silicone and a method for delivering active resveratrol to the skin. | 2009-02-05 |
20090035243 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives - An anhydrous color cosmetic composition comprising at least one resveratrol derivative and particulates; and an anhydrous emulsion skin care composition. | 2009-02-05 |
20090035244 | COSMETIC COMPOSITION COMPRISING FUNCTIONALISED POLY(ALPHA OLEFIN-COPOLYMER-MALEIC ANHYDRIDE) - A cosmetic composition is described comprising functionalised polyanhydrides, specifically functionalised poly(alphaolefin-copolymer-maleic anhydride) copolymers, thereafter also indicated as functionalised polyanhydrides. It is further described a process to prepare such a cosmetic composition by the functionalisation of the polyanhydrides by opening reactions of the anhydride ring with molecules containing at least one OH or NH | 2009-02-05 |
20090035245 | Deodorant cosmetic composition comprising a combination of a lipophilic salicylic acid derivative and an antiperspirant aluminium salt - The present invention relates to a deodorant cosmetic composition comprising: (a) at least one lipophilic salicylic acid derivative of formula (I) below, or a salt thereof: (b) at least one antiperspirant aluminium salt; in an (a)/(b) weight ratio of less than 1/20. The invention also relates to a cosmetic process for treating human perspiration and human body odour, in particular underarm perspiration and underarm odour, using this composition. The invention relates to the use of a combination of at least (a) one lipophilic salicylic acid derivative of formula (I), or a salt thereof, and of at least (b) one antiperspirant aluminium salt, in an (a)/(b) weight ratio of less than 1/20, as a deodorant active agent in a cosmetic composition. | 2009-02-05 |
20090035246 | Long Lasting and Waterproof Lash Extension Composition - Compositions and methods for the in situ formation of cross-linked polymeric filaments are disclosed. The disclosed filaments are preferably elastomeric, water-resistant, oil-resistant, long-wearing. The filament forming compositions generally comprise one or more cross-linkable polymers having at least one functional group capable of forming cross-links and a cross-linking agent, the presence of which promotes cross-linking of the polymers. The compositions may be used for lengthening and/or volumizing keratin fibers, for example, eyelashes. | 2009-02-05 |
20090035247 | METHOD OF STABILIZING A POLYSILOXANE EMULSION AND COMPOSITIONS CONTAINING STABILIZED EMULSIONS - A method of stabilizing an emulsion containing a polysiloxane and one or more surfactants comprising adding an effective amount of dispersion containing a DADMAC/acrylamide copolymer and one or more sulfate salts into said emulsion is disclosed. An emulsion/cosmetically acceptable emulsion comprising a polysiloxane, at least one surfactant, and a dispersion containing DADMAC/acrylamide copolymer and one or more sulfate salts is also disclosed. | 2009-02-05 |
20090035248 | Fast Degrading Polymers - The invention provides polyanhydrides that degrade in less than 60 hours following topical administration to deliver biologically active compounds. | 2009-02-05 |
20090035249 | Method of inhibiting proliferation of Escherichia coli - A method of inhibiting proliferation of | 2009-02-05 |
20090035250 | Compositions and methods for treating cavity conditions - Compositions, methods and kits to be used as a lubricant and for treatment of a cavity pathology including joint pathology are provided. The composition comprises therapeutically effective amounts of at least one bioactive agent, such as magnesium compound, at least one lubricating agent, such as hyaluronic acid, and at least one cell membrane repairing agent, such as polyethylene glycol. The components of these compositions may be administered by a direct application, an application through a cannula, an intra-articular injection, as a flush fluid during an arthroscopy of the affected area, as a post-arthroscopy injection, or as part of a lavage of the area affected by the intra-articular pathology. In addition, the composition of the present invention may be administered to the patient from a pump or a depot. | 2009-02-05 |
20090035251 | METHOD OF APPLYING AN INJECTABLE FILLER - Methods for applying injectable fillers are provided. In some embodiments, the methods can extend effectiveness of the injectable filler. In some embodiments, the methods can provide for an elevated level of effectiveness of the injectable filler. In some embodiments, the methods can prolong the effectiveness of the injectable filler. | 2009-02-05 |
20090035252 | Method of inducing a CTL response - Disclosed herein are methods for inducing an immunological CTL response to an antigen by sustained, regular delivery of the antigen to a mammal so that the antigen reaches the lymphatic system. Antigen is delivered at a level sufficient to induce an immunologic CTL response in a mammal and the level of the antigen in the mammal's lymphatic system is maintained over time sufficient to maintain the immunologic CTL response. Also disclosed is an article of manufacture for delivering an antigen that induces a CTL response in an animal. | 2009-02-05 |
20090035253 | Poly(lactide-Co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar - This invention relates to compositions for the sustained release of biologically active polypeptides, and methods of forming and using said compositions, for the sustained release of biologically active polypeptides. The sustained release compositions of this invention comprise a biocompatible polymer having dispersed therein, a biologically active polypeptide and a sugar. | 2009-02-05 |
20090035254 | IL-21 Variants - IL-21 variant are provided wherein amino acids have been deleted and/or substituted in the region consisting of amino acid No. 65-96. | 2009-02-05 |
20090035255 | CONJUGATE FOR TARGETING OF DRUG - Conjugate for targeting therapeutic or diagnostic agent or drug to cells or tissues in a body, e.g. areas of neoplastic growth or angiogenesis. Use of conjugate for in vivo diagnosis or therapy e.g. inhibiting tumour growth or metastasis, inhibiting angiogenesis and/or treating cancer. Conjugate comprises therapeutic or diagnostic agent as oligomeric protein e.g. heterodimeric protein, wherein first and second subunits of protein are each conjugated to a specific binding member e.g. an antibody fragment such as scFv. Subunits of oligomer may be conjugated to specific binding members as fusion proteins. Conjugate may comprise IL-12 heterodimer having two subunits, each subunit fused to scFv L19 or TN11 for targeting IL-12 to extracellular matrix components associated with neoplastic growth and angiogenesis. | 2009-02-05 |
20090035256 | Mutant Il-10 - IL-10 sequence variants are disclosed that retain the therapeutically desirable anti-inflammatory properties of wild-type IL-10 but do not retain the hemoatopoeitic cell regulatory and cell proliferative activities. The mutant IL-10 polypeptides of the invention are used in methods of treating diseases involving inflammatory response, including neuropathic pain and other neurological disorders. | 2009-02-05 |
20090035257 | Devices, compositions and methods for the protection and repair of cells and tissues - The present invention relates to compositions that reduce the extent of cellular and tissue damage in response to injury or disease. Methods of using the compositions to repair reperfusion injury, and structural tissue damage due to trauma, disease or aging are provided. Also provided are methods of using the compositions to reduce damage to transplanted tissue and organs. The compositions may also be used in oncology applications. | 2009-02-05 |
20090035258 | METHODS OF TREATING CANCER BY ADMINISTERING HUMAN IL-18 COMBINATIONS - The present invention relates generally to the use of human IL-18 combinations in the treatment of various forms of solid tumors and lymphomas. In particular, the present invention relates to: (1) combinations of human IL-18 with monoclonal antibodies against antigens that are expressed on the surface of cancer cells; and (2) combinations of human IL-18 with chemotherapeutic agents. | 2009-02-05 |
20090035259 | GROUP A STREPTOCOCCAL VACCINES - The present invention provides methods for eliciting an immune response against Group A streptococci, comprising use of recombinant fusion polypeptides, and compositions thereof, that include a multivalent immunogenic portion of at least two immunogenic polypeptides from Group A streptococci M proteins (which are capable of stimulating a protective immune response against Group A streptococci), and a reiterated polypeptide from the immunogenic portion carboxy-terminal to the immunogenic portion, wherein the carboxy-terminal polypeptide is not required to stimulate an immune response against Group A streptococci. | 2009-02-05 |
20090035260 | ENHANCED NASAL COMPOSITION OF ACTIVE PEPTIDE - A pharmaceutical composition has a therapeutically effective amount of at least one of: a pharmaceutically active nasal peptide, its pharmaceutically acceptable salt and its peptidic fragment. The composition also contains an absorbefacient effective amount of THAM in a pharmaceutically acceptable, aqueous liquid diluent or carrier. The composition is provided in a convenient form for nasal administration. In one embodiment, the peptidic fragment may be selected physiologically active lymphokines and monokines, peptidic enzymes, proteic vaccines, peptidic toxoids and personalized proteins derived from genoma. In another embodiment, the peptidic fragment may be selected from the peptide hormones and hormone antagonists buserelin, desmopressin, vasopressin, angiotensin, felypressin, octreotide, somatropin, thyrotropin (TSH), somatostatin, gosereline, thryptorelin and insulin selected from the group consisting of cow and pig, synthetic and recombinant. | 2009-02-05 |
20090035261 | IL-17 homologous polypeptides and therapeutic uses thereof - The present invention is directed to novel polypeptides having sequence identity with IL-17, IL-17 receptors and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and hosT-cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases. | 2009-02-05 |
20090035262 | COMPOSITIONS AND METHODS FOR HEALTHY PREGNANCY - Compositions, kits and methods for the prevention of, for example, spontaneous abortion, preeclampsia, preterm labor or implantation failure during assisted reproduction are provided. The compositions, kits and methods provide an effective amount of granulocyte colony stimulating factor to prevent, for example, spontaneous abortion, preeclampsia, preterm labor or implantation failure of an embryo. | 2009-02-05 |
20090035263 | COMPOSITIONS AND METHODS FOR HEALTHY PREGNANCY - Compositions, kits and methods for the prevention of, for example, spontaneous abortion, preeclampsia, preterm labor or implantation failure during assisted reproduction are provided. The compositions, kits and methods provide an effective amount of granulocyte colony stimulating factor to prevent, for example, spontaneous abortion, preeclampsia, preterm labor or implantation failure of an embryo. | 2009-02-05 |
20090035264 | STORAGE STABLE POWDER COMPOSITIONS OF INTERLEUKIN-4 RECEPTOR - The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage. | 2009-02-05 |
20090035265 | Compositions and Methods for Targeted Delivery of Factors - The present invention relates to compositions and methods for targeted delivery of biologically-active factors, such as cytokines, growth factors, chemotherapeutic agents, nucleic acids, and therapeutic agents. The compositions of the present invention can be used to treat diseases and pathologies in organisms. Additionally the invention relates to methods and compositions for the enhancement of an immune response in a human or animal. Such enhancement may result in stimulation or suppression of the immune response. Other compositions and methods of the present invention include vaccines and those used for reduction of the toxicity of agents. | 2009-02-05 |